These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 7526476)

  • 1. [The clinical picture and therapy of malignant pleural mesothelioma].
    Schiebe M; Hoffmann W; Kortmann RD; Bamberg M
    Strahlenther Onkol; 1994 Nov; 170(11):628-35. PubMed ID: 7526476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic options in malignant pleural mesothelioma].
    Serke M; Loddenkemper R
    Pneumologie; 2005 May; 59(5):337-48. PubMed ID: 15902599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality strategies in malignant pleural mesothelioma.
    Weder W; Opitz I; Stahel R
    Semin Thorac Cardiovasc Surg; 2009; 21(2):172-6. PubMed ID: 19822290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.
    Nakas A; Trousse DS; Martin-Ucar AE; Waller DA
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):886-91. PubMed ID: 18656373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.
    Bölükbas S; Manegold C; Eberlein M; Bergmann T; Fisseler-Eckhoff A; Schirren J
    Lung Cancer; 2011 Jan; 71(1):75-81. PubMed ID: 19765853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mesothelioma 2008.
    Zervos MD; Bizekis C; Pass HI
    Curr Opin Pulm Med; 2008 Jul; 14(4):303-9. PubMed ID: 18520263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant pleural mesothelioma: early diagnosis and multimodality management].
    Pavia R; Mondello B; Barone M; Surleti S; Puliafito M; Barresi P
    G Chir; 2005; 26(6-7):257-60. PubMed ID: 16332304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
    In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in treatment of malignant pleural mesothelioma].
    Mahé MA; Cellerin L; Michaud JL; Sagan C; Supiot S; Le Péchoux C
    Cancer Radiother; 2005 Nov; 9(6-7):362-5. PubMed ID: 16219479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Richards WG; Sugarbaker DJ
    Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary treatment of malignant pleural mesothelioma.
    Ceresoli GL; Gridelli C; Santoro A
    Oncologist; 2007 Jul; 12(7):850-63. PubMed ID: 17673616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in malignant pleural mesothelioma.
    Kaufman AJ; Pass HI
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of malignant pleural mesothelioma.
    Butchart EG
    Oncologist; 1999; 4(6):488-500. PubMed ID: 10631693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.
    Wolf AS; Daniel J; Sugarbaker DJ
    Semin Thorac Cardiovasc Surg; 2009; 21(2):132-48. PubMed ID: 19822285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pleural mesothelioma. A case report].
    Della Vittoria Scarpati M; Parascandolo V; Santini M; Di Crescenzo VG; Di Lieto E; Vicidomini G
    Recenti Prog Med; 1999 Jun; 90(6):327-30. PubMed ID: 10399472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.